China Pharma Embraces AI Tools Amid Globalization Challenges
Plus, Senior EU Leaders Seek Level Playing Field
The Chinese biopharma industry is eager to use the latest artificial intelligence technology to boost efficiency and lighten workloads, as companies deal with drastic change and look to improve their understanding of foreign markets. Meanwhile, senior European leaders called for a level playing field during a recent visit to China.
